SEPONVER
SEPONVER
Authorised
- Closantel sodium dihydrate
Product identification
Medicine name:
SEPONVER
Active substance:
- Closantel sodium dihydrate
Target species:
-
Cattle
-
Sheep (ewe lamb)
-
Sheep
-
Sheep (ewe)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Closantel sodium dihydrate54.36/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Cattle
-
Meat and offal55day
-
Milkno withdrawal periodNe pas administrer aux bovins producteurs de lait pour la consommation humaine y compris durant la période de tarissement.
Ne pas utiliser durant la seconde moitié de la gestation chez les génisses qui sont destinées à la production de lait pour la consommation humaine.
-
-
Sheep (ewe lamb)
-
Milk34day34 jours après l’agnelage si la période entre le traitement et l’agnelage est d’au moins 90 jours.
-
Milk120day4 mois après le traitement si la période entre le traitement et l’agnelage est inférieure à 90 jours.
-
-
Sheep
-
Meat and offal55day
-
-
Sheep (ewe)
-
Milk34day34 jours après l’agnelage si la période sèche est d’au moins 90 jours.
-
Milk120day4 mois après le traitement si la période sèche est inférieure à 90 jours.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AG09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Lusomedicamenta Sociedade Tecnica Farmaceutica S.A.
- Lusomedicamenta Sociedade Tecnica Farmaceutica S.A.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/5195635 8/1989
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 2/08/2024
How useful was this page?:
